MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/curroncol32090482

Медицинская библиотека · Current oncology (Toronto, Ont.) · 2025

De-Escalation of Treatment in Women Aged ≥80 Years with Breast Cancer: A Retrospective Analysis from Two Breast Centers.

Piccolino Gianmarco, Cardelli Giulia, Arienzo Francesca, Zarba Meli Emanuele, Del Giudice Elena, Costarelli Leopoldo, Rossi Rosalinda, Scaringi Claudia, Mastropietro Tiziana, Broglia Laura, Vitale Valeria, Bergamo Federica, Manna Elena, La Pinta Massimo, Palleschi Lorenzo, Loreti Andrea, Lombardi Augusto, Fortunato Lucio

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Breast cancer is frequently diagnosed in older women. However, the impact of surgery on survival is not well studied and prognosis for women ≥ 80 years of age is progressively depending on comorbidities.

METHODS

Medical records of consecutive women aged ≥ 80 years diagnosed with primary breast cancer treated with upfront surgery at two Breast Centers from 2011 to 2021 were retrospectively analyzed.

RESULTS

A total of 553 consecutive women with a median age of 83 years and a median tumor diameter of 21 mm were analyzed (574 lesions). Clinical Stages II or III were found in 263/574 (46%) and 101/574 cases (18%), respectively. Axillary staging was completely omitted for 94/542 invasive lesions (17%), and this increased over time from 2% to 33% (p < 0.001). Adjuvant hormone therapy and radiotherapy were omitted in 134/490 (27%) and in 122/420 patients (29%), respectively, while only 26/195 (13%) of patients with a clear clinical indication received adjuvant chemotherapy. At a median follow-up of 61 months (6-147) the 5- and 10-years overall survival (OS) were 64% and 21%, while breast cancer-specific survival (BCSS) at 5 and 10 years were 94% and 78%, respectively. Adjuvant therapies were not associated with a significant improvement in BCSS, while worse OS was associated with older age or more comorbidities as measured by the Charlson Comorbidity Index (CCI) (p < 0.001 and p = 0.012, respectively).

CONCLUSIONS

Breast surgery, when possible, has a primary role even for women > 80 years of age, and it is associated with a reasonable BCSS. De-escalation of adjuvant therapies should be considered in this setting because survival is largely determined by age and co-morbidities.

Для цитирования: Piccolino Gianmarco, Cardelli Giulia, Arienzo Francesca, Zarba Meli Emanuele, Del Giudice Elena, Costarelli Leopoldo, Rossi Rosalinda, Scaringi Claudia, Mastropietro Tiziana, Broglia Laura, Vitale Valeria, Bergamo Federica, Manna Elena, La Pinta Massimo, Palleschi Lorenzo, Loreti Andrea, Lombardi Augusto, Fortunato Lucio. De-Escalation of Treatment in Women Aged ≥80 Years with Breast Cancer: A Retrospective Analysis from Two Breast Centers.. Current oncology (Toronto, Ont.). 2025. DOI: 10.3390/curroncol32090482.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.